The Food and Drug Administration (FDA) recently gave approval for clinical trials in the U.S. of a COVID-19 nasal vaccine ...

The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or inhalation. A nasal COVID-19 vaccine, developed using technology from Washington ...

Hyderabad-based Bharat Biotech Ltd announced the launch of its oral cholera vaccine (OCV) Hillchol. This vaccine was ...

Hyderabad: Vaccine maker Bharat Biotech invested Rs 1,500 crore in setting up what is touted as one of the world's largest vaccine manufacturing facilities at the Odisha Biotech Park in Bhubaneswar.

A nasal vaccine for COVID-19 - based on technology developed at Washington University in St. Louis - is poised to enter a ...

A version of the vaccine has been available in India since 2022 through a licensing agreement between WashU and the Indian biotechnology company Bharat Biotech. The Phase 1 trial is funded through ...

Dr Krishna Ella, co-founder of Bharat Biotech, has been awarded the prestigious INSA India fellowship for 2025 for his significant contributions to vaccine technology and biotechnology.

Dr. Krishna Ella, co-founder and Executive Chairman of Bharat Biotech International, one of India’s leading vaccine makers, was earlier this week conferred with the India Fellowship of the ...

The plant is expected to have the capacity to produce eight billion doses of vaccines per annum. Shanmugaratnam visited Sapigen Biologix (a subsidiary of Bharat Biotech) at its state-of-the-art ...

Singapore President Tharman Shanmugaratnam visited the vaccine manufacturing facility of Sapigen Biologix, a subsidiary of Bharat Biotech, on Saturday, in Bhubaneswar. Located at the Odisha ...

The announcement was made by Bharat Biotech on Tuesday, recognizing Dr. Ella’s remarkable contributions to the field of biotechnology and vaccines. Dr. Ella, a prominent scientist in the ...

Close to 3 decades, Bharat Biotech has been in the forefront of vaccine discovery, manufacturing and distribution having delivered more than 9 billion doses of vaccines to over 125 countries.